a biopharmaceutical company, which focuses on treatments for rare muscle diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, KROS has been loosely correlated with INZY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then INZY could also see price increases.
Ticker / NAME | Correlation To KROS | 1D Price Change % | ||
---|---|---|---|---|
KROS | 100% | -7.31% | ||
INZY - KROS | 43% Loosely correlated | -2.65% | ||
XENE - KROS | 42% Loosely correlated | -0.07% | ||
TFFP - KROS | 40% Loosely correlated | N/A | ||
DNLI - KROS | 39% Loosely correlated | -0.30% | ||
XNCR - KROS | 38% Loosely correlated | +2.12% | ||
More |